Gastric cancer (GC), the fifth most common cancer globally, remains the leading cause of
cancer deaths worldwide. Inflammation-induced tumorigenesis is the predominant process …

Gastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million
people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric …

Gastric cancer (GC) is the third leading cause of cancer deaths and the fourth most prevalent
malignancy worldwide. The high incidence and mortality rates of gastric cancer result from …

Purpose It is important to comprehend how the molecular mechanisms shift when gastric
cancer in its early stages (GC). We employed integrative bioinformatics approaches to locate …

Gastric Cancer (GC) is a common cancer worldwide with a high morbidity and mortality rate
in Asia. Many prognostic signatures from genes and non-coding RNA (ncRNA) levels have …

To date, there has been no multi-omic analysis characterizing the intricate relationships
between the intragastric microbiome and gastric mucosal gene expression in gastric …

Early diagnosis and progression assessment are critical for the timely detection and
treatment of gastric cancer (GC) patients. Identification of diagnostic biomarkers for early …

Gastric cancer (GC) is one of the five most common cancers in the world and unfortunately
has a high mortality rate. To date, the pathogenesis and disease genes of GC are unclear …

Stomach adenocarcinoma (STAD) is a leading cause of cancer deaths, and the outcome of
the patients remains dismal for the lack of effective biomarkers of early detection. Recent …

Gastric cancer (GC) is a prevalent disease worldwide with high mortality and poor treatment
success. Early diagnosis of GC and forecasting of its prognosis with the use of biomarkers …